tetano
Editor, Senior Moderator
Virol J
. 2024 Aug 23;21(1):196.
doi: 10.1186/s12985-024-02433-8. Unlocking influenza B: exploring molecular biology and reverse genetics for epidemic control and vaccine innovation
Ghayyas Ud Din[SUP] 1 2 [/SUP], Chunchen Wu[SUP] 3 [/SUP], Zahra Tariq[SUP] 4 [/SUP], Kinza Hasham[SUP] 4 [/SUP], Muhammad Nabeel Amjad[SUP] 1 2 [/SUP], Bei Shen[SUP] 1 [/SUP], Lihuan Yue[SUP] 1 [/SUP], Muhammad Asif Raza[SUP] 1 2 [/SUP], Muhammad Awais Ashraf[SUP] 1 2 [/SUP], Lingdie Chen[SUP] 1 2 [/SUP], Yihong Hu[SUP] 5 6 [/SUP]
Affiliations
Influenza is a highly contagious acute viral illness that affects the respiratory system, posing a significant global public health concern. Influenza B virus (IBV) causes annual seasonal epidemics. The exploration of molecular biology and reverse genetics of IBV is pivotal for understanding its replication, pathogenesis, and evolution. Reverse genetics empowers us to purposefully alter the viral genome, engineer precise genetic modifications, and unveil the secrets of virulence and resistance mechanisms. It helps us in quickly analyzing new virus strains by viral genome manipulation and the development of innovative influenza vaccines. Reverse genetics has been employed to create mutant or reassortant influenza viruses for evaluating their virulence, pathogenicity, host range, and transmissibility. Without this technique, these tasks would be difficult or impossible, making it crucial for preparing for epidemics and protecting public health. Here, we bring together the latest information on how we can manipulate the genes of the influenza B virus using reverse genetics methods, most importantly helper virus-independent techniques.
Keywords: Disease control; IBV; Influenza; Reverse genetics; Virus.
. 2024 Aug 23;21(1):196.
doi: 10.1186/s12985-024-02433-8. Unlocking influenza B: exploring molecular biology and reverse genetics for epidemic control and vaccine innovation
Ghayyas Ud Din[SUP] 1 2 [/SUP], Chunchen Wu[SUP] 3 [/SUP], Zahra Tariq[SUP] 4 [/SUP], Kinza Hasham[SUP] 4 [/SUP], Muhammad Nabeel Amjad[SUP] 1 2 [/SUP], Bei Shen[SUP] 1 [/SUP], Lihuan Yue[SUP] 1 [/SUP], Muhammad Asif Raza[SUP] 1 2 [/SUP], Muhammad Awais Ashraf[SUP] 1 2 [/SUP], Lingdie Chen[SUP] 1 2 [/SUP], Yihong Hu[SUP] 5 6 [/SUP]
Affiliations
- PMID: 39180083
- PMCID: PMC11344405
- DOI: 10.1186/s12985-024-02433-8
Influenza is a highly contagious acute viral illness that affects the respiratory system, posing a significant global public health concern. Influenza B virus (IBV) causes annual seasonal epidemics. The exploration of molecular biology and reverse genetics of IBV is pivotal for understanding its replication, pathogenesis, and evolution. Reverse genetics empowers us to purposefully alter the viral genome, engineer precise genetic modifications, and unveil the secrets of virulence and resistance mechanisms. It helps us in quickly analyzing new virus strains by viral genome manipulation and the development of innovative influenza vaccines. Reverse genetics has been employed to create mutant or reassortant influenza viruses for evaluating their virulence, pathogenicity, host range, and transmissibility. Without this technique, these tasks would be difficult or impossible, making it crucial for preparing for epidemics and protecting public health. Here, we bring together the latest information on how we can manipulate the genes of the influenza B virus using reverse genetics methods, most importantly helper virus-independent techniques.
Keywords: Disease control; IBV; Influenza; Reverse genetics; Virus.